Overview
Tay-Sachs disease, B1 variant (also called Tay-Sachs B1 variant or the pseudo-deficiency/late-onset B1 variant) is a rare inherited condition that belongs to the family of GM2 gangliosidoses. This entry is now considered obsolete in some classification systems because it has been reclassified or merged with other forms of Tay-Sachs disease. However, the B1 variant is a distinct biochemical subtype caused by mutations in the HEXA gene, which provides instructions for making part of an enzyme called hexosaminidase A (Hex A). In this variant, the enzyme appears to work normally on artificial laboratory substrates but fails to break down the natural substance GM2 ganglioside in the brain. This leads to a toxic buildup of GM2 ganglioside in nerve cells, causing progressive damage to the brain and spinal cord. The B1 variant typically presents later than classic infantile Tay-Sachs disease, often in late infancy or childhood. Children may initially develop normally but then begin to lose skills they had already learned, such as sitting, crawling, or speaking. Symptoms can include progressive muscle weakness, loss of coordination, speech difficulties, vision problems, seizures, and intellectual decline. The rate of progression can vary, but the disease is generally severe and life-shortening. There is currently no cure for Tay-Sachs disease, B1 variant. Treatment is supportive and focuses on managing symptoms such as seizures, feeding difficulties, and respiratory problems. Research into gene therapy, enzyme replacement therapy, and substrate reduction therapy is ongoing, offering hope for future treatments.
Also known as:
Key symptoms:
Loss of previously learned skills (developmental regression)Progressive muscle weaknessDifficulty walking and loss of coordinationSpeech problems or loss of speechVision lossSeizuresIntellectual declineDifficulty swallowingIncreased startle response to loud noisesMuscle stiffness or spasticityBehavioral changesTremors or involuntary movements
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Tay-Sachs disease, B1 variant.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Tay-Sachs disease, B1 variant at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Tay-Sachs disease, B1 variant.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Tay-Sachs disease, B1 variant.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Tay-Sachs disease, B1 variant.
Start the conversation →Latest news about OBSOLETE: Tay-Sachs disease, B1 variant
No recent news articles for OBSOLETE: Tay-Sachs disease, B1 variant.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific HEXA mutations does my child have, and what does this mean for the expected disease course?,How can we best manage seizures, and what are the side effects of the medications?,When should we consider a feeding tube, and how will we know it's time?,Are there any clinical trials or experimental treatments my child might be eligible for?,What therapies (physical, occupational, speech) are recommended, and how often?,Should other family members be tested as carriers, and what does this mean for future pregnancies?,What palliative care and support services are available for our family?
Common questions about OBSOLETE: Tay-Sachs disease, B1 variant
What is OBSOLETE: Tay-Sachs disease, B1 variant?
Tay-Sachs disease, B1 variant (also called Tay-Sachs B1 variant or the pseudo-deficiency/late-onset B1 variant) is a rare inherited condition that belongs to the family of GM2 gangliosidoses. This entry is now considered obsolete in some classification systems because it has been reclassified or merged with other forms of Tay-Sachs disease. However, the B1 variant is a distinct biochemical subtype caused by mutations in the HEXA gene, which provides instructions for making part of an enzyme called hexosaminidase A (Hex A). In this variant, the enzyme appears to work normally on artificial labo
How is OBSOLETE: Tay-Sachs disease, B1 variant inherited?
OBSOLETE: Tay-Sachs disease, B1 variant follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.